全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

A Case of Premature Ovarian Failure in a 33-Year-Old Woman

DOI: 10.1155/2013/573841

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objective. To assess aetiology of a POF in a 33-year-old woman and, if possible, plan a cure. Design. Case report. Setting. medical genetics diagnostic unit in a university hospital. Patient. A 33-year-old woman with premature ovarian failure (POF). Intervention(s). Genetic counseling, karyotyping, FISH study. Result(s). Turner-like diagnosis. Conclusion(s). Most cases of POF remain idiopathic. Turner syndrome can occur in very different phenotypes; cytogenetic and molecular profiling can provide a definitive diagnosis in cases with nonclassical phenotype. 1. Introduction The average of age of the menopause is 50 years [1] with one percent of women menstruating after the age of 60 and one percent entering menopause before the age of 40. Hereditary and environmental (smoking habit) factors affect the age of the natural menopause. A menopause before the age of 40 is commonly defined as “premature ovarian failure” although this definition is arbitrary. Estimates of the prevalence of premature ovarian failure range between 0.3 and 1% and this condition accounts for 10–28% of women with primary amenorrhoea and 4–18% of women with secondary amenorrhoea [2] (Table 1). Table 1: Causes of premature ovarian failure. Some of the causes of POF listed above are extremely rare—particularly the genetic causes. For instance only a few women with FSH-receptor or LH-receptor mutations have ever been reported. In order to give an idea of how common various conditions are, here is a list of the causes of POF in women attending a specialist clinic at the Middlesex Hospital, London, UK (Table 2). Table 2: Causes of POF in women attending a specialist clinic at the Middlesex hospital, London, UK from [ 2]. 10 to 30% of women with POF already have a concurrent autoimmune disorder the most common of which is hypothyroidism. In the sequence of the most common autoimmune associations found in APSII, ovarian failure can occur at any stage. Thus, a history should include symptoms of Addison’s disease, hypothyroidism, and diabetes in particular with the rarer association of autoimmune arthitides and inflammatory bowel disease being kept in mind. Further, women with established POF should be monitored for the later appearance of these conditions. The only features of history which are helpful in determining aetiology of ovarian failure are positive a family history, a concurrent autoimmune disorder, or stigmata of one of the inherited conditions. In many instances a formal pedigree enquiry is required to determine other female family members who may be affected, particularly if the

References

[1]  J. P. de Bruin, H. Bovenhuis, P. A. H. van Noord et al., “The role of genetic factors in age at natural menopause,” Human Reproduction, vol. 16, no. 9, pp. 2014–2018, 2001.
[2]  D. Goswami and G. S. Conway, “Premature ovarian failure,” Human Reproduction Update, vol. 11, no. 4, pp. 391–410, 2005.
[3]  http://www.endocrineonline.org/pdf%20box/pof.pdf, 2012.
[4]  http://www.ncbi.nlm.nih.gov/mesh/68014424, 2012.
[5]  S. Blachford, Gale Encyclopedia of Genetic Disorders, Thomson Gale, 1st edition, 2002.
[6]  G. Day, A. Szvetko, L. Griffiths et al., “SHOX gene is expressed in vertebral body growth plates in idiopathic and congenital scoliosis: implications for the etiology of scoliosis in turner syndrome,” Journal of Orthopaedic Research, vol. 27, no. 6, pp. 807–813, 2009.
[7]  A. L. J. Alexander, Y. N. Mirian, M. F. A. Funari, et al., “Baixa estatura por haploinsuficiência do gene SHOX: do diagnóstico ao tratamento,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 52, no. 5, pp. 765–773, 2009.
[8]  Rosa R. S. Martins, I. B. Ramos Hilda, Juan C. Llerena Jr., and José C.C. Almeida, “Investiga??o clínica e genética em meninas com baixa estatura idiopática,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 47, no. 6, pp. 684–694, 2003.
[9]  A. D. Guedes, B. Bianco, E. Q. Callou, A. L. Gomes, M. V. N. Lipay, and I. T. N. Verreschi, “Growth hormone treatment in turner syndrome: data and reflections,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 52, no. 5, pp. 757–764, 2008.
[10]  http://ghr.nlm.nih.gov/gene/SHOX, 2012.
[11]  G. del Rey, H. Jasper, S. V. Bengolea, A. Boywitt, R. de Bellis, and J. J. Heinrich, “Trisomy of the short stature homeobox-containing gene (SHOX) due to duplication/deletion of the X chomosome: clinical implications on the stature,” Hormone Research in Paediatrics, vol. 74, no. 4, pp. 297–304, 2010.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413